1. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008;Paulozzi;MMWR Morb Mortal Wkly Rep,2011
2. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. www.samhsa.gov/data/2k12/DAWN096/SR096EDHighlights2010.htm. Accessed August 4, 2012.
3. Blumenschein K, Fink JL III, Freeman PR, et al. Review of prescription drug monitoring programs in the United States. http://chfs.ky.gov/NR/rdonlyres/85989824-1030-4AA6-91E1-7F9E3EF68827/0/KASPEREvaluationPDMPStatusFinalReport6242010.pdf. Accessed May 3, 2011.
4. Drug Enforcement Administration, Office of Diversion Control. State Prescription Drug Monitoring Programs: Questions and Answers—What is the difference between HRPDMP and NASPER?www.deadiversion.usdoj.gov/faq/rx_monitor.htm#10. Accessed September 29, 2011.
5. National Allicance for Model State Drug Laws. Prescription drug monitoring programs (Administration of PDMPs); Executive summary – prescription drug abuse, addiction and diversion: Overview of State Legislative and Policy Initiatives, Part 1 (March 2014). www.namsdl.org/prescription-monitoring-programs.cfm. Accessed May 1, 2014.